Transplant Infectious Disease

Papers
(The H4-Index of Transplant Infectious Disease is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients89
Mucormycosis associated with COVID‐19 in two kidney transplant patients51
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients44
Outcomes of COVID‐19 in solid organ transplant recipients: A matched cohort study43
Organ recovery from deceased donors with prior COVID‐19: A case series42
Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression40
Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real‐world evidence38
Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients35
Impact of COVID‐19 in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis35
Treatment of immunocompromised COVID‐19 patients with convalescent plasma34
Mucormycosis in post‐COVID‐19 renal transplant patients: A lethal complication in follow‐up32
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch29
Letermovir prophylaxis in solid organ transplant—Assessing CMV breakthrough and tacrolimus drug interaction28
Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee27
Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature27
Hepatitis C‐positive donor to negative recipient kidney transplantation: A real‐world experience27
The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors26
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis26
Antibody response to two doses of inactivated SARS‐CoV‐2 vaccine (CoronaVac) in kidney transplant recipients26
An International survey on living kidney donation and transplant practices during the COVID‐19 pandemic26
Feasibility and safety of remdesivir in SARS‐CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation24
Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients24
Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy23
0.13705587387085